Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients

Contributed by: PR Newswire

Tags

Orexa-Phase-2

More Like This

PR Newswire associated0

Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

PR Newswire associated0

Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

Orexo shares new information on OX124, a high-dose naloxone rescue medication in development for opioid overdose

PR Newswire associated0

Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024

Orexo announces data from the MODIA® study evaluating impact on use of illicit opioids

Orexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose

Orexo Q3 2023 Interim Report

PR Newswire associated0

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia